MX2020011208A - Composiciones de los o-glicosil flavonoides. - Google Patents
Composiciones de los o-glicosil flavonoides.Info
- Publication number
- MX2020011208A MX2020011208A MX2020011208A MX2020011208A MX2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A MX 2020011208 A MX2020011208 A MX 2020011208A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- composition
- glycosyl
- arginine
- flavonoids
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 229930003935 flavonoid Natural products 0.000 title 1
- 235000017173 flavonoids Nutrition 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 2
- 229930064664 L-arginine Natural products 0.000 abstract 2
- 235000014852 L-arginine Nutrition 0.000 abstract 2
- 150000002340 glycosyl compounds Chemical class 0.000 abstract 2
- 150000002772 monosaccharides Chemical class 0.000 abstract 2
- 150000002016 disaccharides Chemical class 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862661255P | 2018-04-23 | 2018-04-23 | |
| US201862720651P | 2018-08-21 | 2018-08-21 | |
| PCT/JP2019/017262 WO2019208574A1 (en) | 2018-04-23 | 2019-04-23 | Compositions of o-glycosyl flavonoids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2020011208A true MX2020011208A (es) | 2021-01-08 |
Family
ID=66589824
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2020011208A MX2020011208A (es) | 2018-04-23 | 2019-04-23 | Composiciones de los o-glicosil flavonoides. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US11266671B2 (pt) |
| EP (1) | EP3752162A1 (pt) |
| JP (1) | JP6764206B2 (pt) |
| CN (1) | CN112218641A (pt) |
| BR (1) | BR112020021788A8 (pt) |
| CA (1) | CA3098108C (pt) |
| MX (1) | MX2020011208A (pt) |
| TW (1) | TWI761672B (pt) |
| WO (1) | WO2019208574A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI761672B (zh) | 2018-04-23 | 2022-04-21 | 日商阿爾卑斯藥品工業股份有限公司 | O-醣苷基類黃酮之組成物 |
| US10617705B1 (en) * | 2019-01-24 | 2020-04-14 | Alps Pharmaceutical Ind. Co., Ltd. | Isoquercitrin compositions |
| US10918654B1 (en) * | 2019-09-23 | 2021-02-16 | Alps Pharmaceutical Ind. Co., Ltd. | Rutin compositions |
| US11110109B2 (en) * | 2019-10-22 | 2021-09-07 | Alps Pharmaceutical Ind. Co., Ltd. | Water soluble O-glycosyl flavonoid compositions and methods for preparing same |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2451772A (en) | 1946-12-27 | 1948-10-19 | Univ Temple | Solubilization of rutin with methyl glucamine |
| US2646428A (en) | 1949-09-20 | 1953-07-21 | Dausse Lab | Rutin derivatives and production thereof |
| US2975168A (en) | 1957-07-04 | 1961-03-14 | Zyma Sa | Process of preparation of a tri-(hydroxyethyl) ether of rutin |
| US4285964A (en) | 1979-08-30 | 1981-08-25 | Continental Pharma | Salts of (+)-catechine, their preparation and use, and compositions containing these salts |
| EP0075626A1 (en) | 1981-09-29 | 1983-04-06 | American Cyanamid Company | Novel rutin nona- and deca(H-)sulfate salts, methods of preparing novel salts, and use of novel salts of complement inhibitors |
| JPS59232054A (ja) | 1983-06-14 | 1984-12-26 | Nippon Shokuhin Kako Kk | 健康飲食品の製造方法 |
| GB8628228D0 (en) | 1986-11-26 | 1986-12-31 | Inst Biolog Morya Dalnevostoch | Composition inhibiting pathological addiction to alcohol |
| JP2926411B2 (ja) | 1989-03-08 | 1999-07-28 | 株式会社林原生物化学研究所 | α―グリコシル ルチンの製造方法とその用途 |
| JP3212706B2 (ja) * | 1992-08-05 | 2001-09-25 | 日本食品化工株式会社 | 飲食物 |
| EP0960572A1 (en) | 1998-05-12 | 1999-12-01 | N.V. Nutricia | Nutritional composition for the treatment of pressure ulcers |
| JP2002523456A (ja) | 1998-08-27 | 2002-07-30 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | アスコルビン酸塩−イソケルセチン組成物 |
| CA2367387C (en) | 1999-03-16 | 2009-06-23 | Herwig Buchholz | Composition comprising isoquercetin and ascorbic acid in a sustained release form |
| JP2003171274A (ja) | 2001-12-07 | 2003-06-17 | Tomihiko Higuchi | 薬剤耐性菌感染症治療のための医薬組成物および消毒剤 |
| US20060099239A1 (en) | 2002-04-15 | 2006-05-11 | Coleman Henry D | Dietary supplement for promoting removal of heavy metals from the body |
| US20040229825A1 (en) * | 2003-05-13 | 2004-11-18 | Tomihiko Higuchi | Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant |
| DE10321725A1 (de) * | 2003-05-14 | 2004-12-02 | Mucos Pharma Gmbh & Co | Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke |
| US7691425B2 (en) * | 2003-09-29 | 2010-04-06 | San-Ei Gen F.F.I., Inc. | Method for manufacturing α-glycosylisoquercitrin, intermediate product and by-product thereof |
| JP2005198642A (ja) | 2003-12-15 | 2005-07-28 | Yutaka Miyauchi | 柑橘類の果皮を原材料とする液状飲用物 |
| US20050148906A1 (en) * | 2003-12-24 | 2005-07-07 | Gregory Skover | Apparatus for treatment of the skin having a signaling marker |
| US20060083727A1 (en) * | 2004-07-15 | 2006-04-20 | Nanobac Pharmaceuticals, Inc. | Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation |
| EP1832659A1 (en) | 2004-12-28 | 2007-09-12 | Suntory Logistics Limited | Quercetin glycoside composition and method of preparing the same |
| JP5088873B2 (ja) | 2005-07-04 | 2012-12-05 | 国立大学法人 東京医科歯科大学 | Ｌ−アルギニン含有医薬組成物及び飲食品用組成物 |
| JPWO2007114304A1 (ja) | 2006-03-29 | 2009-08-20 | 三栄源エフ・エフ・アイ株式会社 | ベンゼン生成抑制剤およびベンゼン生成抑制方法 |
| JP4914758B2 (ja) | 2006-05-09 | 2012-04-11 | 花王株式会社 | 液体調味料 |
| JP4790561B2 (ja) * | 2006-10-12 | 2011-10-12 | 東洋精糖株式会社 | フラボノイド組成物、その製造方法および用途 |
| US20100204204A1 (en) | 2007-06-06 | 2010-08-12 | University Of South Florida | Nutraceutical co-crystal compositions |
| WO2009018326A2 (en) * | 2007-07-31 | 2009-02-05 | Limerick Biopharma, Inc. | Soluble pyrone analogs methods and compositions |
| DE202008006741U1 (de) | 2008-05-19 | 2009-10-01 | Langhoff, Gertrud | Nährstoffzusammensetzung zur Vitalisierung |
| CZ2008407A3 (cs) | 2008-06-26 | 2009-08-26 | Agra Group, A. S. | Vodorozpustný prípravek na bázi flavanonol lignanu a zpusob jeho prípravy |
| WO2009158031A2 (en) | 2008-06-27 | 2009-12-30 | Limerick Biopharma, Inc. | Methods and compositions for therapeutic treatment |
| CN101301477B (zh) * | 2008-07-04 | 2010-06-09 | 山西大学 | 异槲皮苷包合物及其制备方法 |
| WO2010029913A1 (ja) | 2008-09-11 | 2010-03-18 | 株式会社林原生物化学研究所 | 気力改善剤 |
| WO2010053833A1 (en) | 2008-11-04 | 2010-05-14 | Vymedic, Llc | Antiviral supplement formulations |
| JP2010126503A (ja) | 2008-11-28 | 2010-06-10 | Yamano:Kk | Ｌ−アスコルビン酸の安定化方法、調製液体抽出物、固体状抽出物、半流動体抽出物 |
| WO2010110328A1 (ja) | 2009-03-25 | 2010-09-30 | 三栄源エフ・エフ・アイ株式会社 | 水易溶性イソクエルシトリン組成物 |
| JP2010248148A (ja) | 2009-04-17 | 2010-11-04 | Rohto Pharmaceut Co Ltd | アドバンスド・グリケーション・エンド・プロダクツ分解剤 |
| WO2011104667A1 (en) * | 2010-02-25 | 2011-09-01 | Anthem Biosciences Private Limited | Basic aminoacid salts of polyphenols |
| US10391096B2 (en) | 2011-10-13 | 2019-08-27 | Quercegen Pharmaceuticals Llc | Method for treating thrombotic disorders using quercetin-containing compositions |
| RU2545905C1 (ru) * | 2013-12-16 | 2015-04-10 | Гарри Захарович Казиев | Водорастворимая фармацевтическая композиция l-аргинин-дигидрокверцетин и способ ее получения |
| JP6378513B2 (ja) | 2014-03-24 | 2018-08-22 | アサヒ飲料株式会社 | ヘスペリジン含有飲料、苦味改善剤及び苦味改善方法 |
| JP2015208241A (ja) | 2014-04-24 | 2015-11-24 | 三栄源エフ・エフ・アイ株式会社 | 健康食品 |
| EP3384786B1 (en) * | 2015-12-04 | 2022-03-09 | San-Ei Gen F.F.I., INC. | Use of enzyme-modified isoquercitrin |
| JP6880757B2 (ja) | 2016-01-22 | 2021-06-02 | 大正製薬株式会社 | 経口液体組成物 |
| EP3733860A1 (en) | 2017-07-28 | 2020-11-04 | Taiyo Kagaku Co., Ltd. | Flavonoid inclusion compounds |
| US10603302B2 (en) | 2017-08-23 | 2020-03-31 | Roman Aleksandrovich | Water soluble flavonoids |
| TWI761672B (zh) | 2018-04-23 | 2022-04-21 | 日商阿爾卑斯藥品工業股份有限公司 | O-醣苷基類黃酮之組成物 |
| US11446319B2 (en) | 2018-06-01 | 2022-09-20 | Taiyo Kagaku Co., Ltd. | Composition containing flavonoid-cyclodextrin clathrate compound |
-
2019
- 2019-04-03 TW TW108111997A patent/TWI761672B/zh active
- 2019-04-23 MX MX2020011208A patent/MX2020011208A/es unknown
- 2019-04-23 BR BR112020021788A patent/BR112020021788A8/pt active Search and Examination
- 2019-04-23 JP JP2019564551A patent/JP6764206B2/ja active Active
- 2019-04-23 WO PCT/JP2019/017262 patent/WO2019208574A1/en unknown
- 2019-04-23 EP EP19724944.4A patent/EP3752162A1/en active Pending
- 2019-04-23 US US16/497,746 patent/US11266671B2/en active Active
- 2019-04-23 CN CN201980027924.1A patent/CN112218641A/zh active Pending
- 2019-04-23 CA CA3098108A patent/CA3098108C/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3752162A1 (en) | 2020-12-23 |
| JP6764206B2 (ja) | 2020-09-30 |
| CA3098108A1 (en) | 2019-10-31 |
| BR112020021788A8 (pt) | 2022-12-20 |
| US20210379093A1 (en) | 2021-12-09 |
| JP2020524130A (ja) | 2020-08-13 |
| CN112218641A (zh) | 2021-01-12 |
| TWI761672B (zh) | 2022-04-21 |
| US11266671B2 (en) | 2022-03-08 |
| TW201943415A (zh) | 2019-11-16 |
| WO2019208574A1 (en) | 2019-10-31 |
| CA3098108C (en) | 2023-01-10 |
| BR112020021788A2 (pt) | 2021-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020011208A (es) | Composiciones de los o-glicosil flavonoides. | |
| MX2013014265A (es) | Glicolipidos de cadena larga utiles para evitar el deterioro o la contaminacion microbiana de materiales. | |
| MX2009007415A (es) | Sacaridos modificados. | |
| MX2013013638A (es) | Composicion de oligosacaridos y galactosacaridos de la leche para formula para lactantes que contiene la fraccion soluble de oligosacaridos presente en la leche y que tiene un bajo nivel de monosacaridos y un proceso para producir la composicion. | |
| MX2017008043A (es) | Compuestos de glicósido de esteviol, composiciones para ingesta por vía oral o uso oral y metodo para mejorar la solubilidad del glicósido de esteviol. | |
| BR112018068683A2 (pt) | glicosídeos de esteviol altamente solúveis | |
| PH12015502514A1 (en) | An amorphous and crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase | |
| NZ593882A (en) | Process for the synthesis of l-fucosyl di- or oligosaccharides and novel 2,3,4 tribenzyl-fucosyl derivatives intermediates thereof | |
| DE2965370D1 (en) | Sugar derivatives of c-076 compounds, their preparation and their use as antiparasitic agents | |
| MY158326A (en) | Glycoside derivatives and uses thereof | |
| NZ590306A (en) | Compound comprising a mineral-amino acid conjugated to a polysaccharide and process for its preparation | |
| TW200637915A (en) | The quercetin glycoside composition and its adjustment approach | |
| NO20083590L (no) | Biocidblandinger inneholdende pyrition- og pyrrolderivativer | |
| GEP20094822B (en) | Intermediate and process for preparing of beta- anomer enriched 21-deoxy, 21, 21-difluoro-d-ribofuranosyl nucleosides | |
| MX2022000996A (es) | Nuevo glucosido de esteviol, metodo para su produccion y composicion endulzante que contiene al mismo. | |
| NZ758479A (en) | Novel steviol glycoside and production method therefor, and sweetener composition containing same | |
| TW200833371A (en) | Process for solid formulations | |
| MY192148A (en) | Steviol glycoside composition | |
| BRPI0519819A2 (pt) | composição aquosa de amaciamento de tecidos | |
| AR057555A1 (es) | Un inhibidor de fosfodiesterasa-4 4-oxo-1-(3-sustituido fenil-1,4-dihidro-1,8-naftiridin-3-carboxamida y un procedimiento de preparacion del mismo | |
| NO20082710L (no) | Fremstilling av sure propionater | |
| WO2014044779A3 (en) | Anti-dandruff sugars | |
| IL198848A (en) | Sodium salt of a disaccharide compound, a method of manufacture and use thereof | |
| EP1849467A4 (en) | SYNERGIC PHARMACEUTICAL PREPARATION CONTAINING BAICALEIN AND BAICALIN AND INTENDED FOR INHIBITION OF A TUMOR | |
| BR112014004267A2 (pt) | derivado de ácido pirrolidina-3-ilacético |